Effect of flow on first-pass metabolism of drugs: Single pass studies on 4-methylumbelliferone conjugation in the serially perfused rat intestine and liver preparations

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 1, 1997, Pages 24-31

  Chen, Jinping ^a   Sandy Pang, K ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYMECROMONE;

ANIMAL EXPERIMENT; ARTICLE; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG SCREENING; FIRST PASS EFFECT; INTESTINE BLOOD FLOW; INTESTINE PERFUSION; LIVER BLOOD FLOW; LIVER PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; HYMECROMONE; INTESTINES; LIVER; MALE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 8244231924     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. AHMAD, A., BENNETT, P. N. AND ROWLAND, M.: Models of hepatic drug clearances: discrimination between the "well-stirred" and "parallel tube" models. J. Pharm. Pharmacol. 35: 219-224, 1983.
2. BRAUER, R. W., LEONG, G. F., McELROY, R. F. AND HOLLOWAY, R. J.; Hemodynamics of the vascular tree of the isolated rat liver preparation. Am. J. Physiol. 186: 537-542, 1956.
3. CHOU, C. C., MANGINO, M. J. AND SAWMILLER, D. R.: Gastrointestinal hormones and intestinal blood flow. In Physiology of the Intestinal Circulation, ed. by A. P. Shepherd and D. N. Granger, pp. 121-130, Raven Press, New York, 1984.
4. DAWSON, J. R., WEITERING, J. G., MULDER, G. J., STILLWELL, R. N. AND PANG, K. S.: Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation. J. Pharmacol. Exp. Ther. 234: 691-697, 1985.
5. DELANNOY, I. A. M. AND PANG, K. S.: Combined recirculation of the rat liver and kidney; Studies with enalapril and enalaprilat. J. Pharmacokinet. Biopharm. 21: 423-456, 1993.
6. EL-MOUELHI, M. AND KAUFFMAN, F. C.: Sublobular distribution of transferasen and hydrolases associated with glucuronide, sulfate and glutathione conjugation in human liver. Hepatology 6: 450-456, 1986.
7. GRANGER, D. N., RICHARDSON, P. D. I., KVIETYS, P. R. AND MORTILLARO, N. A.; Intestinal blood flow. Gastroenterology 78: 837-863, 1980.
8. HIRAYAMA, H. AND PANG, K. S.: First-pass metabolism of gentisamide: Influence of intestinal metabolism on hepatic formation of conjugates. Studies in the once-through vascularly perfused rat intestine-liver preparation, Drug Metab. Dispos. 18: 580-587, 1990.
9. HIRAYAMA, H., Xu, X. AND PANG, K. S.: Viability of the vascularly perfused, recirculating rat intestine and intestine-liver preparations. Am. J. Physiol. 257: G249-G258, 1989.
10. JACOBSON, E. D.: The splanchnic circulation. In Gastrointestinal Physiology, 4th ed., , ed. by L. R. Johnson, pp. 142-161, St. Louis, Mosby-Year Book, 1991.
11. LINDROS, K. O.: The once-through perfusion technique-advantages and limitations. In Regulation of Hepatic Metabolism: Alfred Benzoin Symposium VI, ed. by F. Lundqvist and N. Tygstrup, pp. 778-789, Academic Press, Karger, Basal, 1974.
12. MONETA, G. L., TAYLOR, D. C., HELTON, W. S., MULHOLLAND, M. W. AND STRAND-NESS, JR., D. E.: Duplex ultrasound measurement of postprandial intestinal blood flow: Effect of meal composition. Gastroenterology 95: 1294-1301, 1988.
13. MORRIS, M. E. AND PANG, K. S.; Competition between two enzymes for substrate removal in liver: Modulating effects of competitive pathways. J. Pharmacokinet. Biopharm. 15: 473-496, 1987.
14. MORRIS, M. E., YUEN, V., TANG, B. K. AND PANG, K. S.: Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation. J. Pharmacol. Exp. Ther, 245: 614-622, 1988.
15. MULDER, G. J., BROUWER, S. AND SCHOLTENS, E.: High-rate conjugation of 4-methylumbelliferone during intravenous infusion in the rat in vivo. Biochem. Pharmacol. 33: 2341-2344, 1984.
16. MULDER, G. J., BROUWER, S., WEITERING, J. G., SCHOLTENS, E. AND PANG, K. S.: Glucuronidation and sulfation in the rat in vivo. The role of the liver and the intestine in the in vivo clearance of 4-methylumbelliferone. Biochem. Pharmacol. 34: 1325-1329, 1985.
17. OLANOFF, L. S., WALLE, T., COWART, T. D., WALLE, U. K., OXEMANN, M. J. AND CONRADI, E. C.: Food effects on propranolol systemic and oral clearance: Support of a blood flow hypothesis. Clin. Pharmacol. Ther. 40: 408-414, 1986.
18. PANG, K. S.,KOSTER, H., HALSEMA, I.C.M. SCHOLTENS, E. AND MULDER, G. J.: Aberrant pharmacokinetics of harmol in the perfused rat liver preparation: Sulfate and glucuronide conjugations. J. Pharmacol. Exp. Ther. 219: 134140, 1981.
19. PANG, K. S., KOSTER, H., HALSEMA, I. C. M., SOHOLTENS, E., MULDER, G. J. AND STILLWELL, R. N.: Normal and retrograde perfusion to probe the zonal distribution of sulfation and glucuronidation activities of harmol in the perfused rat liver preparation. J. Pharmacol. Exp. Ther. 224: 647-653, 1983.
20. PANG, K. S., LEE, W. F., CHERRY, W. F., YUEN, V., ACCAPUTO, J., FAYZ, S., SCHWAB, A. J. AND GORESKY, C. A.: Effects of perfusate flow rate on measured blood volume, Disse space, intracellular water space, and drug extraction in the perfused rat liver preparation: Characterization by the multiple indicator dilution technique. J. Pharmacokinet. Biopharm. 16: 595-632, 1988.
21. PANG, K. S. AND MULDER, G. J.: A commentary: The effect of flow on formation of metabolites. Drug Metab. Dispos. 18: 270-275, 1990.
22. PANG, K. S. AND ROWLAND, M.: Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cells binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J. Pharmacokinet. Biopharm. 5: 625-653, 1977a.
23. PANG, K. S. AND ROWLAND, M.: Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation. J. Pharmacokinet. Biopharm. 5: 655-680, 1977b.
24. PANG, K. S. AND ROWLAND, M.: Hepatic clearance of drugs, III. Additional experimental evidence supporting the "well-stirred" model using metabolite (MEGX) data generated from lidocaine under varying hepatic blood flow rate and linear conditions in the perfused rat liver in situ preparation. J. Pharmacokinet. Biopharm. 5: 681-690, 1977c.
25. PREMEN, A. J., KVIETYS, P. R. AND GRANGER, D. N.: Postprandial regulation of intestinal blood flow: role of gastrointestinal hormones. Am. J. Physiol. 249: G250-G255, 1985.
26. RATNA, S., CHIBA, M., BANDYOPADHYAY, L. AND PANG, K. S.: Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver. Hepatology 17: 838-853, 1993.
27. SEVERINGHAUS, J. W.: Oxyhemoglobin dissociation curve correction for temperature and pH variation in human blood. J. Appl. Physiol. 12: 485-486, 1958.
28. SHAND, D. G., KORNHAUSER, D. M. AND WILKINSON, G. R.: Effects of route of administration and blood flow on hepatic elimination. J. Pharmacol. Exp. Ther. 195: 424-432, 1975.
29. SHEPHARD, A. P. AND GRANGER, D. N.: Metabolic regulation of the intestinal circulation. In Physiology of The Intestinal Circulation, ed. by A. P. Shepherd and D. N. Granger, pp. 33-47, Raven Press, New York, 1984.
30. SHEPHERD, A. P. AND RIEDEL, G. L.: Laser-Doppler blood flowmetry of intestinal mucosal hyperemia induced by glucose and bile. Am. J. Physiol. 248: G393-G397, 1985.
31. ST-PIERRE, M. V., SCHWAB, A. J., GORRSKY, C. A., LEE, W.-F. AND PANG, K. S.: The multiple indicator dilution technique for characterization of normal and retrograde perfusions in the once-through rat liver preparation. Hepatology 9: 285-296, 1989.
32. SVENSSON, C. K., CUMELLA, J. C., TRONOLONE, M., MIDDLETON, E. AND LALKA, D.: Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow. Clin. Pharmacol. Ther. 37: 464-468, 1985.
33. SVENSSON, C. K., EDWARDS, D. J., MAURIELLO, P. M., BARDE, S. H., FOSTER, A. C., LANC, R. A., MIDDLETON, E. AND LALKA, D.: Effect of food on hepatic blood flow: Implications in the "food effect" phenomenon. Clin. Pharmacol. Ther. 34: 316-323, 1983.
34. WHITSETT, J. L., DAYTON, P. G. AND MCNAY, T. L.: The effect of hepatic blood flow on the hepatic removal rate of oxyphenbutazone in the dog. J. Pharmacol. Exp. Ther. 177: 246-255, 1971.
35. WILKINSON, G. R.: Clearance approaches in pharmacology. Pharmacol. Rev. 39: 1-47, 1987.
36. Xu, X., HIRAYAMA, H. AND PANG, K. S.: First-pass metabolism of salicylamide. Studies in the once-through vascularly perfused rat intestine-liver preparation. Drug Metab. Dispos. 17: 556-563, 1989.
37. Xu, X., TANG, B. K. AND PANG, K. S.: Sequential metabolism of salicylamide exclusively to gentisamide-5-glucuronide and not gentisamide sulfate conjugates in the single pass in situ perfused rat liver. J. Pharmacol. Exp. Ther. 253: 963-973, 1990.
38. Yu, Y. M., Yu, L. C. C. AND CHOU, C. C.: Distribution of blood flow in the intestine with hypertonic glucose in the lumen. Surgery 78: 520-525, 1975.
39. ZIMMERMAN, C. L., RATNA, S., LEBOEUF, E. AND PANG, K. S.: High-performance liquid Chromatographic method for the direct determination of 4-methylumbelliferone and its glucuronide and sulfate conjugates. J. Chromatogr. 563: 83-94, 1991.